Dr Reddy's Gets CDSCO Panel Nod to Manufacture, Market Anticancer Drug Lenalidomide Capsules Dr. Divya Colin26 May 2023 6:00 PM ISTNew Delhi: In a significant development, the drug major Dr. Reddy's Laboratories has got a green signal from the Subject Expert Committee (SEC)...
Continued pricing pressures in US, European Markets to affect profit margins of Indian pharma firms: Ratings agency ICRA Ruchika Sharma6 Jan 2023 2:30 PM ISTICRA said most major Indian pharmaceutical companies continue to focus on emerging markets to fuel their growth, given that they continue to face...
Dr Reddy's Labs unveils cancer drug Lenalidomide in US Ruchika Sharma8 Sept 2022 2:47 PM ISTDr. Reddy's Lenalidomide Capsules are available in strengths of 2.5 mg, 5 mg, and 10 mg, each in a bottle-count size of 28, as well as 15 mg, 20 mg,...
Dr Reddys aims to triple reach to 1.5 billion patients by 2030 Ruchika Sharma9 July 2022 11:00 AM ISTDr Reddy's said it is making its "products accessible and affordable for patients" and "25 percent of new launches to be first to market by 2027".
Dr Reddys to seek regulator nod for single-dose Sputnik Light jab as booster dose Ruchika Sharma20 May 2022 1:24 PM ISTReplying to query on the pricing of Sputnik vaccines, he said they were working on it and it would be in line with the competition.
Glenmark, Dr Reddys and 2 others recall products in US Ruchika Sharma16 May 2022 2:19 PM ISTNew Delhi: Homegrown drug majors Lupin, Glenmark and Dr Reddy's Laboratories are recalling different products in the US, the world's largest market...
Dr Reddys unveils Posaconazole delayed-release tablets in US Ruchika Sharma22 April 2022 12:02 PM ISTHyderabad: Drugmaker, Dr Reddy's Laboratories Ltd. has announced the launch of Posaconazole Delayed-Release Tablets, 100 mg in the...
Dr Reddys unveils Methylprednisolone Sodium Succinate for Injection in US Ruchika Sharma6 April 2022 12:23 PM ISTMethylprednisolone sodium succinate for Injection, USP is an anti-inflammatory glucocorticoid, which contains methylprednisolone sodium succinate as...
Dr Reddys, MediCane Health introduce medical cannabis products in Germany Ruchika Sharma5 April 2022 11:00 AM ISTFor Dr Reddy's, the launch reinforces its presence in Germany's growing medical cannabis market.
Dr Reddy's Labs, Novartis ink pact for cardiovascular brand Cidmus Ruchika Sharma2 April 2022 12:03 PM ISTUnder the agreement, Dr Reddy's will be assigned and transferred the Cidmus trademark in India from Novartis AG for a consideration of USD 61 Million
Russia-Ukraine crisis: Indian pharma exporters in wait and watch mode MD Bureau25 Feb 2022 10:00 AM ISTHyderabad: Amid the military offensive by Russia against Ukraine, Indian pharma exporters are in wait and watch mode on dispatching fresh orders to...
Dr Reddys gets USFDA EIR for Duvvada facilities Ruchika Sharma21 Feb 2022 3:37 PM ISTHyderabad: Pharma major, Dr Reddy's Labs, today announced that the company has received the Establishment Inspection Report (EIR) from the U.S...
